局部晚期食管癌治疗:ASCO指南
指南推荐局部晚期食管癌采用多学科综合治疗;腺癌可术前放化疗或围手术期化疗,鳞癌可术前放化疗或根治性放化疗而不手术。
要点
- 局部晚期食管癌推荐多学科综合治疗。
- 腺癌:术前放化疗或围手术期化疗。
- 鳞癌:术前放化疗或放化疗而不手术。
核心结论
- 局部晚期食管癌推荐多学科综合治疗。
- 腺癌患者应接受术前放化疗或围手术期化疗。
- 鳞癌患者应接受术前放化疗或放化疗而不手术。
研究设计与样本
- ASCO召集专家组对1999-2019年发表的局部晚期食管癌治疗文献进行系统综述。
- 在可能的情况下,按鳞状细胞癌和腺癌分别提取数据。
主要发现
- 在可能的情况下,数据按鳞状细胞癌和腺癌分别提取。
关键数值与推荐
- 局部晚期食管癌推荐多学科综合治疗。
- 腺癌亚组:应提供术前放化疗或围手术期化疗。
- 鳞癌亚组:应提供术前放化疗或放化疗而不手术。
- 指南还提供了额外的亚组考虑以协助推荐实施。
临床怎么用
- 临床决策时应按组织学亚型(腺癌或鳞癌)选择多学科治疗策略。
- 腺癌患者可考虑术前放化疗或围手术期化疗。
- 鳞癌患者可考虑术前放化疗或根治性放化疗而不手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with locally advanced esophageal cancer. METHODS: ASCO convened an Expert Panel to conduct a systematic review of the more recently published literature (1999-2019) on therapy options for patients with locally advanced esophageal cancer and provide recommended care options for this patient population. RESULTS: Seventeen randomized controlled trials met the inclusion criteria. Where possible, data were extracted separately for squamous cell carcinoma and adenocarcinoma. RECOMMENDATIONS: Multimodality therapy for patients with locally advanced esophageal carcinoma is recommended. For the subgroup of patients with adenocarcinoma, preoperative chemoradiotherapy or perioperative chemotherapy should be offered. For the subgroup of patients with squamous cell carcinoma, preoperative chemoradiotherapy or chemoradiotherapy without surgery should be offered. Additional subgroup considerations are provided to assist with implementation of these recommendations. Additional information is available at www.asco.org/gastrointestinal-cancer-guidelines.
引用
- Shah MA, Kennedy EB, Catenacci DV, et al. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. J Clin Oncol. 2020. PMID: 32568633. doi:10.1200/JCO.20.00866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。